Does 2-chlorodeoxyadenosine contribute to alteration of DNA methyltransferase activity?
Wyczechowska
D
D
Department of General Chemistry, Medical University of Lodz, Poland.
Fabianowska-Majewska
K
K
D043383:Adenosylhomocysteinase; D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D001374:Azacitidine / Q000031:analogs & derivatives / Q000494:pharmacology; D017338:Cladribine / Q000494:pharmacology*; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000378:metabolism*; D000077209:Decitabine; D006867:Hydrolases / Q000378:metabolism*; D007700:Kinetics; D007939:Leukemia L1210 / Q000201:enzymology*; D051379:Mice; D014407:Tumor Cells, Cultured; D014740:Vidarabine / Q000031:analogs & derivatives / Q000494:pharmacology
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D017338:Cladribine; D000077209:Decitabine; D004248:DNA (Cytosine-5-)-Methyltransferases; D006867:Hydrolases; D043383:Adenosylhomocysteinase; D014740:Vidarabine; D001374:Azacitidine; C024352:fludarabine